What BPC-157 is, and what has actually been studied

BPC-157 is a pentadecapeptide: a chain of fifteen amino acids. It is not a designed molecule but a partial fragment of a larger protein called body protection compound, isolated from human gastric juice. That origin explains its most-cited property in the literature: it stays stable in gastric juice for more than a day, where most peptides degrade within minutes [1].

What has been studied, and in which species

The overwhelming majority of published work consists of animal models, mostly rat. That belongs at the top rather than in a footnote, because it is what separates an honest reading of the literature from a brochure: what has been observed was observed in rodents.

• Tendon. In a rat Achilles detachment model, the authors describe faster tendon-to-bone reattachment in treated animals, and a blunting of the negative effect corticosteroids had on that same repair [2].
• Tendon culture. In isolated tenocytes, greater cell survival, migration and explant outgrowth were described, which are the three processes that make up tendon repair [3].
• Myotendinous junction. Later work studied the junction between muscle and tendon after an induced injury, again in rat [4].
• Gastrointestinal tract. This is the original and most extensive line of research: ulcer and mucosal damage models [1].

Proposed mechanisms

Reviews describe several overlapping pathways, none of them exclusive to this molecule. The most cited are signalling through the VEGFR2 receptor and nitric oxide production via the Akt-eNOS axis, both linked to new vessel formation and fibroblast activity [5].

Proposed mechanisms are not the same as mechanisms demonstrated in humans. A recent narrative review of its use in musculoskeletal repair points to exactly that gap between the volume of preclinical literature and the absence of comparable clinical evidence [5].

Regulatory status

BPC-157 is not approved as a medicine by the European Medicines Agency, by the Spanish AEMPS, or by their US counterpart. There is no authorised indication, no approved dosing and no validated route of administration for people.

What is sold here is a reagent intended for in vitro research. This page describes what has been published in the scientific literature. It is not medical information, does not describe a therapeutic use, and does not replace any healthcare professional.

What to look at when comparing suppliers

To work with this compound in a laboratory, what decides is not price but three specific facts that should be published without having to ask:

• Purity measured by HPLC, per batch, not a generic product-level figure. Two batches are two manufacturing runs.
• The certificate of analysis for the batch you receive, readable before you buy.
• Shipping and storage conditions: lyophilised, cold, and on a timeline that does not leave the vial sitting a week in a warm warehouse.